Share on LinkedInShare on LinkedIn

ARTICLE · 24 JUNE 2013

Naturally Occurring DNA Is Not Patentable

On June 13, 2013, in a seminal case on the patentability of the genetic code, the U.S. Supreme Court unanimously held that "naturally occurring DNA … is a product of nature and not patent eligible merely because it has been isolated, but that cDNA is patent eligible because it is not naturally occurring."

United StatesIntellectual Property

On June 13, 2013, in a seminal case on the patentability of the genetic code, the U.S. Supreme Court unanimously held that "naturally occurring DNA ... is a product of nature and not patent eligible merely because it has been isolated, but that cDNA is patent eligible because it is not naturally occurring." See Association for Molecular Pathology v. Myriad Genetics Inc. (2013).

While the Myriad decision is anticipated to bring a sea change in how patent claims covering genetic material are drafted, it is important to note what the case does and does not effect:

  • The decision only directly impacts claims directed to compositions of matter; not method claims directed to the use of isolated genes.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from